Abbott Laboratories
ABT
98.49
-0.24
-0.24%
Abbott Laboratories
US · ABT
#113 by market cap
Listed 1970
98.49
-0.24
-0.24%
Live - 5344 symbols - heartbeat 342s ago
· 2026-10-08 17:57
Pre-market
98.55
-0.18%
After-hours
98.48
-0.01%
Overnight
98.75
+0.02%
- Market cap
- 170.43B
- P/E (TTM)i
- 31.87
- P/Bi
- 3.33
- EPSi
- 3.72
- Div yieldi
- 2.48%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on ABT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Dividend Trend how this is computed
Growing
- The 2025 payout was up 7.3% from 2024.
- 2026 is still in progress: 1.89 paid out so far, against 2.36 for all of 2025.
Dividend overview
- Yield (TTM)i
- 2.48%
- Paid (TTM)
- 2.44
- Growth streaki
- 1 yrs
- Next ex-date
- 2026-10-15
Dividends per share by year
Payment history
| Ex-date | Amount | Record | Payable | Announced |
|---|---|---|---|---|
| 2026-10-15 | 0.6300 USD | 2026-10-15 | 2026-11-16 | 2026-09-17 |
| 2026-07-15 | 0.6300 USD | 2026-07-15 | 2026-08-17 | 2026-06-12 |
| 2026-04-15 | 0.6300 USD | 2026-04-15 | 2026-05-15 | 2026-02-20 |
| 2026-01-15 | 0.6300 USD | 2026-01-15 | 2026-02-13 | 2025-12-12 |
| 2025-10-15 | 0.5900 USD | 2025-10-15 | 2025-11-17 | 2025-09-19 |
| 2025-07-15 | 0.5900 USD | 2025-07-15 | 2025-08-15 | 2025-06-13 |
| 2025-04-15 | 0.5900 USD | 2025-04-15 | 2025-05-15 | 2025-02-21 |
| 2025-01-15 | 0.5900 USD | 2025-01-15 | 2025-02-14 | 2024-12-13 |
| 2024-10-15 | 0.5500 USD | 2024-10-15 | 2024-11-15 | 2024-09-19 |
| 2024-07-15 | 0.5500 USD | 2024-07-15 | 2024-08-15 | 2024-06-14 |
| 2024-04-12 | 0.5500 USD | 2024-04-15 | 2024-05-15 | 2024-02-16 |
| 2024-01-11 | 0.5500 USD | 2024-01-12 | 2024-02-15 | 2023-12-15 |
| 2023-10-12 | 0.5100 USD | 2023-10-13 | 2023-11-15 | 2023-09-21 |
| 2023-07-13 | 0.5100 USD | 2023-07-14 | 2023-08-15 | 2023-06-09 |
| 2023-04-13 | 0.5100 USD | 2023-04-14 | 2023-05-15 | 2023-02-17 |
| 2023-01-12 | 0.5100 USD | 2023-01-13 | 2023-02-15 | 2022-12-09 |
Stock splits
- 47847328→100000000 2013-01-02
- 1→2 1998-06-01
Quote time 2026-10-08 17:57:43 · For reference only, not investment advice and not tailored to your situation.